Daniel Barber, President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 400 shares at $6.00 ($2K) on 2025-09-19, disclosed to the SEC on 2025-09-22.
Scheduled sale ($2k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AQST | SELL | 2026-07-17 | $100K | — | Filing → |
| AQST | SELL | 2026-06-16 | $104K | — | Filing → |
| AQST | SELL | 2026-05-18 | $35K | — | Filing → |